Revenues of BIOMERICA INC from 31 May 2011 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
BIOMERICA INC quarterly and annual Revenues in USD history and change rate from 31 May 2011 to 30 Nov 2025.
  • BIOMERICA INC Revenues for the quarter ending 30 Nov 2025 was $1,210,000, a 26% decline year-over-year.
  • BIOMERICA INC Revenues for the twelve months ending 30 Nov 2025 was $4,458,000, a 20% decline year-over-year.
  • BIOMERICA INC annual Revenues for 2024 was $5,311,000, a 1.9% decline from 2023.
  • BIOMERICA INC annual Revenues for 2023 was $5,415,000, a 1.4% increase from 2022.
  • BIOMERICA INC annual Revenues for 2022 was $5,339,000, a 72% decline from 2021.
Source SEC data
View on sec.gov
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)

BIOMERICA INC Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $4,458,000 $1,210,000 -$426,000 -26% 01 Sep 2025 30 Nov 2025 10-Q 14 Jan 2026 2026 Q2
Q3 2025 $4,884,000 $1,380,000 -$427,000 -24% 01 Jun 2025 31 Aug 2025 10-Q 14 Oct 2025 2026 Q1
Q2 2025 $5,311,000 $749,000 -$369,000 -33% 01 Mar 2025 31 May 2025 10-K 29 Aug 2025 2025 FY
Q1 2025 $5,680,000 $1,119,000 +$102,000 +10% 01 Dec 2024 28 Feb 2025 10-Q 14 Apr 2025 2025 Q3
Q4 2024 $5,578,000 $1,636,000 +$69,000 +4.4% 01 Sep 2024 30 Nov 2024 10-Q 14 Jan 2026 2026 Q2
Q3 2024 $5,509,000 $1,807,000 +$94,000 +5.5% 01 Jun 2024 31 Aug 2024 10-Q 14 Oct 2025 2026 Q1
Q2 2024 $5,415,000 $1,118,000 +$9,000 +0.81% 01 Mar 2024 31 May 2024 10-K 29 Aug 2025 2025 FY
Q1 2024 $5,406,000 $1,017,000 -$94,000 -8.5% 01 Dec 2023 29 Feb 2024 10-Q 14 Apr 2025 2025 Q3
Q4 2023 $5,500,000 $1,567,000 +$85,000 +5.7% 01 Sep 2023 30 Nov 2023 10-Q 14 Jan 2025 2025 Q2
Q3 2023 $5,415,000 $1,713,000 +$76,000 +4.6% 01 Jun 2023 31 Aug 2023 10-Q 15 Oct 2024 2025 Q1
Q2 2023 $5,339,000 $1,109,000 -$4,192,812 -79% 01 Mar 2023 31 May 2023 10-K 28 Aug 2024 2024 FY
Q1 2023 $9,531,812 $1,111,000 -$6,549,501 -85% 01 Dec 2022 28 Feb 2023 10-Q 12 Apr 2024 2024 Q3
Q4 2022 $16,081,313 $1,482,000 -$3,164,900 -68% 01 Sep 2022 30 Nov 2022 10-Q 16 Jan 2024 2024 Q2
Q3 2022 $19,246,213 $1,637,000 +$375,213 +30% 01 Jun 2022 31 Aug 2022 10-Q 12 Oct 2023 2024 Q1
Q2 2022 $18,871,000 $5,301,812 +$4,247,755 +403% 01 Mar 2022 31 May 2022 10-K 25 Aug 2023 2023 FY
Q1 2022 $14,623,245 $7,660,501 +$4,031,863 +111% 01 Dec 2021 28 Feb 2022 10-Q 14 Apr 2023 2023 Q3
Q4 2021 $10,591,382 $4,646,900 +$3,274,374 +239% 01 Sep 2021 30 Nov 2021 10-Q 13 Jan 2023 2023 Q2
Q3 2021 $7,317,008 $1,261,787 +$117,981 +10% 01 Jun 2021 31 Aug 2021 10-Q 13 Oct 2022 2023 Q1
Q2 2021 $7,199,027 $1,054,057 -$1,670,942 -61% 01 Mar 2021 31 May 2021 10-K 29 Aug 2022 2022 FY
Q1 2021 $8,869,969 $3,628,638 +$2,451,749 +208% 01 Dec 2020 28 Feb 2021 10-Q 14 Apr 2022 2022 Q3
Q4 2020 $6,418,220 $1,372,526 -$223,882 -14% 01 Sep 2020 30 Nov 2020 10-Q 12 Jan 2022 2022 Q2
Q3 2020 $6,642,102 $1,143,806 -$50,609 -4.2% 01 Jun 2020 31 Aug 2020 10-Q 14 Oct 2021 2022 Q1
Q2 2020 $6,692,711 $2,724,999 +$1,559,139 +134% 01 Mar 2020 31 May 2020 10-K/A 14 Oct 2021 2021 FY
Q1 2020 $5,133,572 $1,176,889 -$84,272 -6.7% 01 Dec 2019 29 Feb 2020 10-Q 14 Apr 2021 2021 Q3
Q4 2019 $5,217,844 $1,596,408 +$95,617 +6.4% 01 Sep 2019 30 Nov 2019 10-Q 14 Jan 2021 2021 Q2
Q3 2019 $5,122,227 $1,194,415 -$78,455 -6.2% 01 Jun 2019 31 Aug 2019 10-Q 15 Oct 2020 2021 Q1
Q2 2019 $5,200,682 $1,165,860 +$35,460 +3.1% 01 Mar 2019 31 May 2019 10-K 31 Aug 2020 2020 FY
Q1 2019 $5,165,222 $1,261,161 -$114,505 -8.3% 01 Dec 2018 28 Feb 2019 10-Q 14 Apr 2020 2020 Q3
Q4 2018 $5,279,727 $1,500,791 -$112,845 -7% 01 Sep 2018 30 Nov 2018 10-Q 14 Jan 2020 2020 Q2
Q3 2018 $5,392,572 $1,272,870 -$171,613 -12% 01 Jun 2018 31 Aug 2018 10-Q 15 Oct 2019 2020 Q1
Q2 2018 $5,564,185 $1,130,400 01 Mar 2018 31 May 2018 10-K 29 Aug 2019 2019 FY
Q1 2018 $1,375,666 -$124,264 -8.3% 01 Dec 2017 28 Feb 2018 10-Q 15 Apr 2019 2019 Q3
Q4 2017 $1,613,636 01 Sep 2017 30 Nov 2017 10-Q 14 Jan 2019 2019 Q2
Q3 2017 $1,444,483 01 Jun 2017 31 Aug 2017 10-Q 15 Oct 2018 2019 Q1
Q1 2017 $1,499,930 01 Dec 2016 28 Feb 2017 10-Q 16 Apr 2018 2018 Q3

BIOMERICA INC Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $5,311,000 -$104,000 -1.9% 01 Jun 2024 31 May 2025 10-K 29 Aug 2025 2025 FY
2023 $5,415,000 +$76,000 +1.4% 01 Jun 2023 31 May 2024 10-K 29 Aug 2025 2025 FY
2022 $5,339,000 -$13,532,000 -72% 01 Jun 2022 31 May 2023 10-K 28 Aug 2024 2024 FY
2021 $18,871,000 +$11,671,973 +162% 01 Jun 2021 31 May 2022 10-K 25 Aug 2023 2023 FY
2020 $7,199,027 +$506,316 +7.6% 01 Jun 2020 31 May 2021 10-K 29 Aug 2022 2022 FY
2019 $6,692,711 +$1,492,029 +29% 01 Jun 2019 31 May 2020 10-K/A 14 Oct 2021 2021 FY
2018 $5,200,682 -$363,503 -6.5% 01 Jun 2018 31 May 2019 10-K 31 Aug 2020 2020 FY
2017 $5,564,185 -$227,485 -3.9% 01 Jun 2017 31 May 2018 10-K 29 Aug 2019 2019 FY
2016 $5,791,670 01 Jun 2016 31 May 2017 10-K 29 Aug 2018 2018 FY
2011 $6,081,000 +$1,182,000 +24% 01 Jun 2011 31 May 2012 10-K 29 Aug 2012 2012 FY
2010 $4,899,000 01 Jun 2010 31 May 2011 10-K 29 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.